FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto) is an Asia-Pacific company.
From "APAC CIO Outlook Magazine", an IT business magazine for the region, "Top 10 Healthcare Technology"
Companies in APAC 2020 (Top 2020 Healthcare Technology Companies in APAC 10)
We announce that we were elected to.

"APAC CIO Outlook Magazine" is headquartered in Silicon Valley, USA, and is located in the Asia Pacific region.
For companies widely subscribed to CxO and IT senior management, including CIOs and CTOs
It is an IT business magazine.

For this election, FRONTEO Life Science AI Business Headquarters Life Science AI
Hiroyoshi Toyoshiba, CTO of division of duties and general manager of R & D department, responded to an interview with the magazine in the medical and pharmaceutical fields.
The importance of EBM (Evidence based Medicine) in utilizing AI in
FRONTEO's proprietary AI engine "Concept Encoder" that realizes EBM with increasing characteristics
Features of "to encoder)", drug discovery search support, dementia diagnosis support utilizing Concept Encoder
We introduced advanced initiatives such as support and fall prediction.

Annie Johnson, Editor-in-Chief of APAC CIO Outlook Magazine, said:
I am saying.

"FRONTEO Selected for Our Top 2020 APAC Healthcare Technology Companies in 10" List
I am glad that it was issued.With this election, FRONTEO's AI technology and advanced measures
The pair will be more appreciated in the market and will get a lot of attention. "

Recently, efforts to utilize AI in the medical and pharmaceutical fields have expanded, aiming for practical application in the medical field.
The movement is becoming more and more active.Along with numerical analysis of images and sensors, conversations, treatises, and questions
Efforts to analyze natural language (text information) such as medical records with AI are also attracting more and more attention.
You.

FRONTEO has been developing AI-based natural language analysis in the life science field since 2014.
At the same time, provide consultation and data analysis services by AI experts.
As a result, we have achieved various results in pharmaceutical companies and medical-related businesses.

* Click here for the interview article (English) (Registration is required to view)
https://www.apacciooutlook.com/magazines/March2020/Healthcare/#page-26　

concept encoderabout　URL: https://lifescience.fronteo.com/

Concept Encoder is an artificial intelligence (AI) developed by FRONTEO specially in the life science field.It was developed in 2018 for the purpose of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence (grounds).We have introduced and realized statistical methods such as the significance test, which is indispensable for "evidence-based medicine (EBM)", which is a common understanding among healthcare professionals, in natural language analysis. Concept Encoder can be co-analyzed with data other than text, and we are conducting research on co-analysis with "numerical data" such as gene expression information, vitals and various test values ​​accumulated in the life science field.Patent registration number: Patent No. XNUMX

FRONTEOabout　URL: https://www.fronteo.com/

FRONTEO Inc. has developed its own artificial intelligence engine "KIBIT".^®(Kibit) ”and“ concept encoder^®(Concept encoder) ”is a data analysis company that supports information analysis such as big data.Established in August 2003 as a company that supports e-discovery (electronic discovery), which preserves, investigates, and analyzes electronic data necessary for international litigation, and digital forensic investigations.In-house developed data analysis platform "Lit i View"^®(Lit Eye View) ”,“ Predictive Coding Predictive Coding^®(Predictive Coding) ”technology is used to provide legal proceedings support to companies.The unique artificial intelligence-related technology cultivated and developed in this legal business learns "tacit knowledge" such as expert experience and intuition, and realizes prediction of future behavior from analysis of human thoughts.We have expanded into areas such as life science and business intelligence, and have achieved results in "work style reform" in addition to FinTech and RegTech. Listed on TSE Mothers on June 2007, 6.The capital is 26 thousand yen (as of March 2,559,206, 2019).